Publications en collaboration avec des chercheurs de Instituto de Biomedicina de Valencia (23)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  3. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2017

  1. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma

    Cell Reports, Vol. 21, Núm. 8, pp. 2183-2197

  2. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells

    Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, Vol. 1860, Núm. 6, pp. 721-729

  3. The PipX Protein, When Not Bound to Its Targets, Has Its Signaling C-Terminal Helix in a Flexed Conformation

    Biochemistry, Vol. 56, Núm. 25, pp. 3211-3224

2016

  1. Assessing the role of TUBA4A gene in frontotemporal degeneration

    Neurobiology of Aging, Vol. 38, pp. 215.e13-215.e14

2015

  1. New insights on the transcriptional regulation of CD69 gene through a potent enhancer located in the conserved non-coding sequence 2

    Molecular Immunology, Vol. 66, Núm. 2, pp. 171-179

2014

  1. Apaf-1 inhibitors protect from unwanted cell death in In vivo models of kidney ischemia and chemotherapy induced ototoxicity

    PLoS ONE, Vol. 9, Núm. 10

  2. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

    Neurobiology of Aging, Vol. 35, Núm. 2, pp. 444.e1-444.e4

2012

  1. LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation

    Movement Disorders, Vol. 27, Núm. 1, pp. 146-150

2011

  1. Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain

    Apoptosis, Vol. 16, Núm. 5, pp. 460-467

  2. Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1

    Human Molecular Genetics, Vol. 20, Núm. 18, pp. 3545-3553

  3. NMR structure and dynamics of recombinant wild type and mutated jerdostatin, a selective inhibitor of integrin α 1β 1

    Proteins: Structure, Function and Bioinformatics, Vol. 79, Núm. 8, pp. 2530-2542

2009

  1. Deciphering the antitumoral activity of quinacrine: Binding to and inhibition of Bcl-xL

    Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 6, pp. 1592-1595

  2. Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study

    Movement Disorders, Vol. 24, Núm. 10, pp. 1437-1444

2008

  1. Design of a bivalent peptide with two independent elements of secondary structure able to fold autonomously

    Journal of Peptide Science, Vol. 14, Núm. 7, pp. 845-854

  2. Molecular mechanisms of atherosclerosis in metabolic syndrome: Role of reduced IRS2-dependent signaling

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 28, Núm. 12, pp. 2187-2194